Improvements in screening test, diagnosis, and outcomes of children with congenital hypothyroidism: lessons learned from 50 years of newborn screening
Authors:
- Mariacarolina SalernoMSMariacarolina Salerno
- Maria Cristina VigoneMVMaria Cristina Vigone
- Alessandra CassioACAlessandra Cassio
- Paolo CavarzerePCPaolo Cavarzere
- Valentino CherubiniValentino Cherubini
- Maria Felicia FaienzaMaria Felicia Faienza
- Roberto GastaldiRGRoberto Gastaldi
- Gerdi TuliGTGerdi Tuli
- Malgorzata WasniewskaMalgorzata Wasniewska
- Antonella OlivieriAOAntonella Olivieri
Open Access
- 8 June 2026
- journal article
- review article
- Published by Springer Nature in Endocrine
- Vol. 91 (1)
Abstract
Congenital hypothyroidism (CH) may result from a developmental or functional defect of the thyroid gland (primary CH), or to hypothalamic-pituitary axis dysfunction (central CH), or more rarely from abnormalities in the action, transport, or metabolism of thyroid hormones. In the absence of prompt initiation of replacement therapy during the neonatal period, CH can lead to profound impairment in growth and neuropsychomotor development. Since signs of CH early in life can be subtle and difficult to recognize, early detection and prompt treatment goals have been achieved by newborn screening (NBS), which was started fifty years ago. A narrative review was conducted to identify studies describing how the evolution of NBS for CH has contributed to improve diagnostic accuracy and outcomes of affected children. From its start, the main objective of NBS for CH has been the eradication of intellectual disability resulting from severe CH. However, over decades it has become clear that CH covers a spectrum of phenotypes, including mild, moderate, and severe forms of hypothyroidism. In addition, numerous outcome studies have confirmed that early CH detection by NBS followed by timely replacement therapy effectively prevents brain damage, underscoring the success and importance of this screening program. The improvement of NBS and advances in the management of CH have dramatically enhanced patient outcomes through increasingly personalized care from birth to adulthood. Although overall outcomes are generally favorable, ongoing monitoring of treatment adequacy and patient adherence remains essential.Keywords
This publication has 167 references indexed in Scilit:
- Liquid formulations of Levothyroxine with ethanol or with parabens for treatment of congenital hypothyroidism: similar TSH and fT4 values in the first 6 months of follow upEndocrine, 2025
- Comparison Between Ultrasonography and Radiography in the Detection of Epiphyseal Ossification Centers of the Knee in Infants With Permanent Congenital HypothyroidismJournal of Ultrasound in Medicine, 2024
- Diagnosing and treating anterior pituitary hormone deficiency in pediatric patientsReviews in Endocrine and Metabolic Disorders, 2023
- Consequences of undertreatment of hypothyroidismEndocrine, 2023
- Genetics of congenital hypothyroidism: Modern conceptsPediatric Investigation, 2022
- Ocular morphology development and function in children with congenital hypothyroidism diagnosed by neonatal screeningEndocrine, 2020
- Incidence of primary congenital hypothyroidism and relationship between diagnostic categories and associated malformationsEndocrine, 2020
- A New Definition of Genetic Counseling: National Society of Genetic Counselors’ Task Force ReportJournal of Genetic Counseling, 2006
- Action of thyroid hormone in brainJournal of Endocrinological Investigation, 2002
- Assessment of skeletal maturation in infants: comparison between two methods in hypothyroid patientsPediatric Radiology, 1998